Amundi Boston Scientific Corp Transaction History
Amundi
- $276 Billion
- Q2 2025
A detailed history of Amundi transactions in Boston Scientific Corp stock. As of the latest transaction made, Amundi holds 10,199,754 shares of BSX stock, worth $1.05 Billion. This represents 0.4% of its overall portfolio holdings.
Number of Shares
10,199,754
Previous 12,308,715
17.13%
Holding current value
$1.05 Billion
Previous $1.24 Billion
11.77%
% of portfolio
0.4%
Previous 0.45%
Shares
17 transactions
Others Institutions Holding BSX
# of Institutions
1,904Shares Held
1.27BCall Options Held
9.73MPut Options Held
7.07M-
Vanguard Group Inc Valley Forge, PA137MShares$14.1 Billion0.25% of portfolio
-
Black Rock Inc. New York, NY126MShares$13 Billion0.22% of portfolio
-
State Street Corp Boston, MA65.2MShares$6.69 Billion0.27% of portfolio
-
Primecap Management CO Pasadena, CA34.7MShares$3.56 Billion3.04% of portfolio
-
Bank Of America Corp Charlotte, NC33.8MShares$3.47 Billion0.27% of portfolio
About BOSTON SCIENTIFIC CORP
- Ticker BSX
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,431,609,984
- Market Cap $147B
- Description
- Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...